Cardio Diagnostics Holdings Inc
CDIO3.950USD
+0.070+1.80%
Market hours （ET）Quotes delayed by 15 min
228.93KMarket Cap
LossP/E TTM
More Details of Cardio Diagnostics Holdings Inc Company
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Company Info
Ticker SymbolCDIO
Company nameCardio Diagnostics Holdings Inc
IPO dateNov 23, 2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Number of employees13
Security typeOrdinary Share
Fiscal year-endNov 23
Address311 W. Superior Street
CityCHICAGO
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code60645
Phone18552269991
Website
Ticker SymbolCDIO
IPO dateNov 23, 2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
-34.96%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Paul Burton, J.D.
Mr. Paul Burton, J.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
-34.96%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Dogan (Meeshanthini)
3.17%
Bd Holding, Inc
3.04%
BlackRock Institutional Trust Company, N.A.
2.05%
Geode Capital Management, L.L.C.
0.76%
The Vanguard Group, Inc.
0.71%
Other
90.27%
Shareholders
Shareholders
Proportion
Dogan (Meeshanthini)
3.17%
Bd Holding, Inc
3.04%
BlackRock Institutional Trust Company, N.A.
2.05%
Geode Capital Management, L.L.C.
0.76%
The Vanguard Group, Inc.
0.71%
Other
90.27%
Shareholder Types
Shareholders
Proportion
Individual Investor
4.21%
Investment Advisor
3.47%
Corporation
3.04%
Investment Advisor/Hedge Fund
0.97%
Research Firm
0.16%
Hedge Fund
0.12%
Venture Capital
0.11%
Other
87.91%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
44
210.25K
12.09%
-12.08K
2025Q1
46
215.87K
12.62%
-11.61K
2024Q4
51
6.58M
12.62%
+556.91K
2024Q3
70
5.72M
21.51%
-4.06M
2024Q2
76
5.70M
26.20%
-6.56M
2024Q1
73
5.54M
28.62%
-6.62M
2023Q4
73
5.55M
28.89%
-5.24M
2023Q3
68
4.28M
41.11%
-6.26M
2023Q2
64
4.02M
40.37%
-6.37M
2023Q1
59
3.90M
40.53%
-6.83M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Dogan (Meeshanthini)
55.18K
3.17%
--
--
Mar 20, 2025
Bd Holding, Inc
52.88K
3.04%
--
--
Mar 20, 2025
BlackRock Institutional Trust Company, N.A.
35.57K
2.05%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
13.17K
0.76%
+1.02K
+8.41%
Mar 31, 2025
The Vanguard Group, Inc.
12.42K
0.71%
+4.68K
+60.47%
Mar 31, 2025
UBS Financial Services, Inc.
5.57K
0.32%
+3.35K
+150.95%
Mar 31, 2025
Dogan (Timur)
4.28K
0.25%
-2.30K
-34.96%
Mar 20, 2025
Hosseinion (Warren)
3.87K
0.22%
--
--
Mar 20, 2025
Philibert (Robert)
3.25K
0.19%
--
--
Mar 20, 2025
Jane Street Capital, L.L.C.
2.69K
0.15%
-1.06K
-28.20%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
